Abiopharma

News list

Director Egan Kevin Francis 🟢 acquired 7.3K shares (1 derivative) of PERRIGO Co plc (PRGO) Transaction Date: May 14, 2025 | Filing ID: 000084

Full text

News bot Sept. 23, 2025, 6:03 a.m.
🔍 Egan Kevin Francis (Director)

Company: PERRIGO Co plc (PRGO)

Report Date: 2025-05-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 7,305
- Total shares held: 0
Detailed Transactions and Holdings:
- Holds 0 shares of No securities are beneficially owned (Direct)
  Date: 2025-05-14 | Code: H
- Acquired 7,305 shares of Restricted Stock Units (Derivative)
  Date: 2025-05-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,305.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2
Footnotes:
- F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
- F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026.